Patent details

Basic Information

Publication number:

EP3463309

PCT Application Number:

EP2017062516

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP177262623

PCT Publication Number:

WO2017207375

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FIXED DOSE COMBINATION OF TELMISARTAN, HYDROCHLOROTHIAZIDE AND AMLODIPINE

French Title of Invention:

COMBINAISON DE DOSE FIXE DE TELMISARTAN, DE L'HYDROCHLOROTHIAZIDE ET DE L'AMLODIPINE

German Title of Invention:

FESTDOSEN-KOMBINATION VON TELMISARTAN, HYDROCHLOROTHIAZID UND AMLODIPIN

SPC Number:

Dates

Filing date:

24/05/2017

Grant date:

17/06/2020

EP Publication Date:

10/04/2019

PCT Publication Date:

07/12/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/06/2020

EP B1 Publication Date:

17/06/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/05/2021

Expiration date:

24/05/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/06/2020

 

 

Name:

Boehringer Ingelheim International GmbH

Address:

Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Inventor

1

Name:

YOKOYAMA, Kazutoshi

Address:

Germany (DE)

2

Name:

NAKATANI, Manabu

Address:

Germany (DE)

3

Name:

SEKI, Noriko

Address:

Germany (DE)

Priority

Priority Number:

16171934

Priority Date:

30/05/2016

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

A61K 9/20; A61K 9/24; A61K 31/4184; A61K 31/4422; A61K 31/495;

Publication

European Patent Bulletin

Issue number:

202025

Publication date:

17/06/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages